Neuronal Ceroid Lipofuscinosis: The increasing spectrum of an old disease

Current Molecular Medicine

Volumn 14, Issue 8, 2014, Pages 1043-1051

  Simonati, A ^a   Pezzini, F ^a   Moro, F ^b   Santorelli, F M ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

Author keywords

NCL epidemiology; NCL genes; NCL pathogenesis; NCL pathology; NCL phenotypes; NCL treatments

Indexed keywords

CYCLOPHILIN; MEMBRANE PROTEIN; SECRETORY PROTEIN;

ARTICLE; AUTOPHAGY; DISEASE COURSE; EPILEPSY; EXCITOTOXICITY; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; NEURONAL CEROID LIPOFUSCINOSIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PHENOTYPE; SEIZURE;

EID: 84911470703     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524014666141010154913     Document Type: Article

References (50)

1. Mole SE, Williams RE, Goebel HH. The Neuronal Ceroid Lipofuscinoses (Batten Disease). 2nd edition. Oxford: Oxford University Press; 2011.
2. Williams RE. Appendix 1: NCL incidence and prevalence data. In: The Neuronal Ceroid Lipofuscinoses (Batten Disease). 2nd edition; Mole SE, Williams RE, Goebel HH (Eds). Oxford: Oxford University Press; 2011: pp. 361-363.
3. Augestad LB, Flanders WD. Occurrence of and mortality from childhood neuronal ceroid lipofuscinoses in Norway. J Child Neurol 2006; 21: 917-922.
4. Verity C, Winstone AM, Stellitano L, Will R, Nicoll A. The epidemiology of progressive intellectual and neurological deterioration in childhood. Arch Dis Child 2010; 95: 361-364.
5. Santorelli FM, Garavaglia B, Cardona F, et al. Molecular epidemiology of childhood neuronal ceroid-lipofuscinosis in Italy. Orphanet J Rare Dis 2013; 8: 19.
6. Moore SJ, Buckley DJ, MacMillan A, et al. The clinical and genetic epidemiology of neuronal ceroid lupofuscinosis in Newfoundland. Clin Genet 2008; 74: 213-222.
7. Stengel C. Beretning om et mærkeligt Sygdomstilfælde hos fire Sødskende i Nærheden af Røraas. Eyr Med Tidskr 1826; 1: 347-352.
8. Haltia M. The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol 2003; 62: 1-13.
9. Haltia M, Goebel HH. The Neuronal ceroid-lipofuscinoses: a historical perspective. Biochim Biophys Acta 2013; 1832: 1795-1800.
10. Anderson GW, Goebel HH, Simonati A. Human Pathology in NCL. Biochim Biophys Acta 2013; 1832: 1807-1826.
11. Zeman W, Dyken P. Neuronal ceroid-lipofuscinosis (Batten's disease): relationship to amaurotic family idiocy? Pediatrics 1969; 44: 570-583.
12. Williams RE, Goebel HH, Mole SE, et al. NCL nomenclature and classification. In: Mole SE, Williams RE, Goebel HH (Eds). The Neuronal Ceroid Lipofuscinoses (Batten Disease), 2nd edition. Oxford: Oxford University Press; 2011: pp. 20-23.
13. Williams RE, Mole SE. New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses. Neurology 2012; 79: 183-191.
14. Kollmann K, Uusi-Rauva K, Scifo E, et al. Cell biology and function of neuronal ceroid lipofuscinosis related protein. Biochim Biophys Acta 2013; 1832: 1866-1881.
15. Kohlschutter A, Williams RE, Goebel HH, et al. NCL diagnosis and algorithms. In: Mole SE, Williams RE, Goebel HH (Eds). The Neuronal Ceroid Lipofuscinoses (Batten Disease), 2nd edition. Oxford: Oxford University Press; 2011: pp. 24-34.
16. Azizieh R, Orduz D, Van Bogaert P, et al. Progressive myoclonic epilepsy-associated gene KCTD7 is a regulator of potassium conductance in neurons. Mol Neurobiol 2011; 44: 111-121.
17. Staropoli JF, Karaa A, Lim ET, et al. A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system. Am J Hum Genet 2012; 91: 202-208.
18. Bras J, Verloes A, Schneider SA, et al. Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis. Hum Mol Genet 2012; 21: 2646-2650.
19. Berkovic SF, Carpenter S, Andermann F, et al. Kufs' disease: a critical reappraisal. Brain 1988; 111: 27-62.
20. Noskova' L, Stra'necky V, Hartmannova H, et al. Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal dominant adult-onset neuronal ceroid lipofuscinosis. Am J Hum Genet 2011; 89: 241-252.
21. Arsov T, Smith KR, Damiano J, et al. Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6. Am J Hum Genet 2001; 88: 566-573.
22. Smith KR, Dahl HH, Canafoglia L, et al. Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis. Hum Mol Genet 2013; 22: 1417-1423.
23. Smith KR, Damiano J, Franceschetti S, et al. Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am J Hum Genet 2012; 90: 1102-1107.
24. Palmer DN, Fearnley IM, Walker JE, et al. Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am J Med Genet 1992; 42: 561-567.
25. Tyynelä J, Palmer DN, Baumann M, Haltia M. Storage of saposins A and D in infantile neuronal ceroid-lipofuscinosis. FEBS Lett 1993; 330: 8-12.
26. Oswald MJ, Palmer DN, Kay GW, et al. Glial activation spreads from specific cerebral foci and precedes neurodegeneration in presymptomatic ovine neuronal ceroid lipofuscinosis (CLN6). Neurobiol Dis 2005; 20: 49-63.
27. Cooper JD, Russell C, Mitchison HM. Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis. Biochim Biophys Acta 2006; 1762: 873-889.
28. Pearce DA, Atkinson M, Tagle DA. Glutamic acid decarboxylase autoimmunity in Batten disease and other disorders. Neurology 2004; 63: 2001-2005.
29. Kay GW, Palmer DN, Rezaie P, Cooper JD. Activation of non-neuronal cells within the prenatal developing brain of sheep with neuronal ceroid lipofuscinosis Brain Pathol 2006; 16: 110-116.
30. Groh J, Kuhl TG, Ip CW, et al. Immune cells perturb axons and impair neuronal cell survival in a mouse model of infantile ceroid lipofuscinosis. Brain 2013; 136: 1083-1101.
31. Palmer DN, Barry LA, Tyynela J, Cooper JD. NCL disease mechanisms. Biochim Biophys Acta 2013; 1832: 1882-1893.
32. Luiro K, Yliannala K, Ahtiainen L, et al. Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway. Hum Mol Genet 2004; 13: 3017-3027.
33. Ahtiainen L, Luiro K, Kauppi M, et al. Palmitoyl protein thioesterase 1 (PPT1) deficiency causes endocytic defects connected to abnormal saposin processing, Exp Cell Res 2006; 312: 1540-1553.
34. Kovacs AD, Weimer JM, Pearce DA. Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease. Neurobiol Dis 2006; 22: 575-585.
35. Finn R, Kovács A, Pearce DA. Altered glutamate receptor function in the cerebellum of the Ppt1-/-mouse, a murine model of infantile neuronal ceroid lipofuscinosis. J Neurosci Res 2012; 90: 367-375.
36. Kim SJ, Zhang Z, Sarkar C, et al. Palmitoyl protein thioesterase-1 deficiency impairs synaptic vesicle recycling at nerve terminals, contributing to neuropathology in humans and mice. J Clin Invest 2008; 118: 3075-3086.
37. Koch S, Molchanova SM, Wright AK, et al. Morphologic and functional correlates of synaptic pathology in the cathepsin D knockout mouse model of congenital neuronal ceroid lipofuscinosis. J Neuropathol Exp Neurol 2011: 70: 1089-1096.
38. Sharma M, Burré J, Bronk P, et al. CSPα knockout causes neurodegeneration by impairing SNAP-25 function EMBO J 2011; 31: 829-841.
39. Cannelli N, Garavaglia B, Simonati A, et al. Variant late infantile ceroid lipofuscinoses associated with novel mutations in CLN6. Biochem Biophys Res Commun 2009; 379: 892-897.
40. Koike M, Shibata M, Waguri S, et al. Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease). Am J Pathol 2005; 167: 1713-1728.
41. Cao Y, Espinola JA, Fossale E, et al. Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. J Biol Chem 2006; 281: 20483-20493.
42. Thelen M, Damme M, Schweizer M, et al. disruption of the autophagy-lysosome pathway is involved in neuropathology of the nclf mouse model of neuronal ceroid lipofuscinosis. PLoS One 2012; 7: e35493.
43. Oresic K, Mueller B, Tortorella D. CLN6 mutants associated with Neuronal Ceroid Lipofuscinosis are degraded in a proteasome manner. Biosci Rep 2009; 29: 173-181.
44. Zhang Z, Lee YC, Kim SJ, et al. Palmitoyl-protein thioesterase-1 deficiency mediates the activation of the unfolded protein response and neuronal apoptosis in INCL. Hum Mol Genet 2006; 15: 337-346.
45. Galizzi G, Russo D, Deidda I, et al. Different early ER-stress responses in the CLN8(mnd) mouse model of neuronal ceroid lipofuscinosis. Neurosci Lett 2011; 488: 258-262.
46. Pezzini F, Gismondi F, Tessa A, et al. Involvement of the mitochondrial compartment in human NCL fibroblasts. Biochem Biophys Res Commun 2011; 416: 159-164.
47. Lu J-Y, Hofmann SL. Inefficient cleavage of palmitoyl-protein thioesterase (PPT) substrates by aminothiols: implications for treatment of infantile neuronal ceroid lipofuscinosis. J Inherit Metab Dis 2006; 29: 119-126.
48. Passini MA, Dodge JC, Bu J, et al. Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis. J Neurosi 2006; 26: 1334-1342.
49. Macauley SL, Roberts MS, Wong AM, et al. Synergistic effects of central nervous system-directed gene therapy and bone marrow transplantation in the murine model of infantile neuronal ceroidlipofuscinosis. Ann Neurol 2012; 71: 797-804.
50. Kohan R, Cismondi IA, Oller-Ramirez AM, et al. Therapeutic approaches to the Challenge of Neuronal Ceroid Lipofuscinoses. Curr Pharm Biotech 2011; 12: 867-883.